• OPEN AN ACCOUNT
Indian Indices
Nifty
26,068.15 -124.00
(-0.47%)
Sensex
85,231.92 -400.76
( -0.47%)
Bank Nifty
58,867.70 -480.00
( -0.81%)
Nifty IT
36,885.35 -157.95
( -0.43%)
Global Indices
Nasdaq
45,781.42 -378.36
(-0.82%)
Dow Jones
6,560.44 -102.72
(-1.54%)
Hang Seng
48,653.14 -1,170.80
(-2.35%)
Nikkei 225
9,535.95 8.30
(0.09%)
Forex
USD-INR
88.50 -0.07
(-0.08%)
EUR-INR
102.33 -0.31
(-0.31%)
GBP-INR
115.99 -0.49
(-0.42%)
JPY-INR
0.57 0.00
(-0.62%)

EQUITY - MARKET SCREENER

Cipla Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500087
INE059A01026
411.5600262
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CIPLA
23.76
123504.18
EPS(TTM)
Face Value()
Div & Yield %
64.35
2
1.05
 

Embassy Developments reports consolidated net loss of Rs 153.32 crore in the September 2025 quarter
Nov 07,2025
Net Loss of Embassy Developments reported to Rs 153.32 crore in the quarter ended September 2025 as against net loss of Rs 34.34 crore during the previous quarter ended September 2024. Sales rose 3.71% to Rs 493.11 crore in the quarter ended September 2025 as against Rs 475.47 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales493.11475.47 4
OPM %-10.6016.03 -
PBDT-143.96-22.60 -537
PBT-152.49-27.46 -455
NP-153.32-34.34 -346